nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxtriphylline—PDE3B—pancreas—bile duct cancer	0.0142	0.131	CbGeAlD
Oxtriphylline—PDE3B—liver—bile duct cancer	0.00905	0.0834	CbGeAlD
Oxtriphylline—HDAC2—pancreas—bile duct cancer	0.00836	0.0771	CbGeAlD
Oxtriphylline—PDE4D—liver—bile duct cancer	0.00755	0.0696	CbGeAlD
Oxtriphylline—PDE3B—lymph node—bile duct cancer	0.00694	0.064	CbGeAlD
Oxtriphylline—PDE4B—pancreas—bile duct cancer	0.00626	0.0577	CbGeAlD
Oxtriphylline—ADORA2A—liver—bile duct cancer	0.00624	0.0575	CbGeAlD
Oxtriphylline—SLC22A7—liver—bile duct cancer	0.00618	0.057	CbGeAlD
Oxtriphylline—PDE4D—lymph node—bile duct cancer	0.00579	0.0534	CbGeAlD
Oxtriphylline—PDE3A—liver—bile duct cancer	0.00553	0.051	CbGeAlD
Oxtriphylline—HDAC2—liver—bile duct cancer	0.00532	0.049	CbGeAlD
Oxtriphylline—PDE4A—lymph node—bile duct cancer	0.00512	0.0472	CbGeAlD
Oxtriphylline—PDE3A—lymph node—bile duct cancer	0.00424	0.0391	CbGeAlD
Oxtriphylline—ADORA1—lymph node—bile duct cancer	0.00413	0.0381	CbGeAlD
Oxtriphylline—HDAC2—lymph node—bile duct cancer	0.00408	0.0376	CbGeAlD
Oxtriphylline—PDE4B—liver—bile duct cancer	0.00398	0.0367	CbGeAlD
Oxtriphylline—PDE4B—lymph node—bile duct cancer	0.00305	0.0282	CbGeAlD
Oxtriphylline—CYP1A2—liver—bile duct cancer	0.00245	0.0226	CbGeAlD
Oxtriphylline—PDE4C—Signaling by GPCR—GNAS—bile duct cancer	0.00184	0.00206	CbGpPWpGaD
Oxtriphylline—CYP1A2—Arachidonic acid metabolism—PTGS2—bile duct cancer	0.00182	0.00205	CbGpPWpGaD
Oxtriphylline—SLC22A7—Transmembrane transport of small molecules—GNAS—bile duct cancer	0.00181	0.00203	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—GNAS—bile duct cancer	0.00179	0.00201	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—ERBB2—bile duct cancer	0.00179	0.00201	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—GNAS—bile duct cancer	0.00176	0.00198	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—GNAS—bile duct cancer	0.00168	0.00188	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—GNAS—bile duct cancer	0.00168	0.00188	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—ERBB2—bile duct cancer	0.00167	0.00187	CbGpPWpGaD
Oxtriphylline—ADORA1—Circadian rythm related genes—TP53—bile duct cancer	0.00166	0.00187	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—NRAS—bile duct cancer	0.00165	0.00185	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—GNAS—bile duct cancer	0.00163	0.00183	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—GNAS—bile duct cancer	0.00163	0.00183	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—GNAS—bile duct cancer	0.0016	0.0018	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—RNF43—bile duct cancer	0.00159	0.00178	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—GNAS—bile duct cancer	0.00157	0.00176	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—GNAS—bile duct cancer	0.00155	0.00174	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—GNAS—bile duct cancer	0.00153	0.00171	CbGpPWpGaD
Oxtriphylline—ADORA1—Circadian rythm related genes—IL6—bile duct cancer	0.00152	0.00171	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	0.00152	0.0017	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—NOS2—bile duct cancer	0.00151	0.00169	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—bile duct cancer	0.0015	0.00168	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—GNAS—bile duct cancer	0.00148	0.00166	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—RNF43—bile duct cancer	0.00148	0.00166	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—GNAS—bile duct cancer	0.00143	0.0016	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—bile duct cancer	0.00142	0.00159	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—GNAS—bile duct cancer	0.00141	0.00158	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—bile duct cancer	0.00141	0.00158	CbGpPWpGaD
Oxtriphylline—HDAC2—Circadian rythm related genes—TP53—bile duct cancer	0.00138	0.00155	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	0.00138	0.00155	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.00138	0.00155	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—NRAS—bile duct cancer	0.00136	0.00153	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	0.00131	0.00146	CbGpPWpGaD
Oxtriphylline—ADORA2A—Circadian rythm related genes—TP53—bile duct cancer	0.00129	0.00144	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—NRAS—bile duct cancer	0.00127	0.00142	CbGpPWpGaD
Oxtriphylline—HDAC2—Circadian rythm related genes—IL6—bile duct cancer	0.00127	0.00142	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—EGFR—bile duct cancer	0.00124	0.00139	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—GNAS—bile duct cancer	0.00121	0.00136	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—bile duct cancer	0.00121	0.00135	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—NRAS—bile duct cancer	0.00119	0.00133	CbGpPWpGaD
Oxtriphylline—ADORA2A—Circadian rythm related genes—IL6—bile duct cancer	0.00118	0.00132	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—KRAS—bile duct cancer	0.00117	0.00132	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—EGFR—bile duct cancer	0.00115	0.00129	CbGpPWpGaD
Oxtriphylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—bile duct cancer	0.00115	0.00129	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TGFBR2—bile duct cancer	0.00113	0.00126	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	0.00111	0.00125	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—GNAS—bile duct cancer	0.0011	0.00124	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—TGFB1—bile duct cancer	0.0011	0.00124	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—KRAS—bile duct cancer	0.00109	0.00122	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—GNAS—bile duct cancer	0.00109	0.00122	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—NRAS—bile duct cancer	0.00108	0.00121	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—SMAD4—bile duct cancer	0.00107	0.0012	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—SMAD4—bile duct cancer	0.00106	0.00119	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—TGFBR2—bile duct cancer	0.00104	0.00116	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TGFBR2—bile duct cancer	0.00103	0.00115	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—KRAS—bile duct cancer	0.00102	0.00114	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—FAR2—bile duct cancer	0.001	0.00113	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—TGFB1—bile duct cancer	0.001	0.00113	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TGFBR2—bile duct cancer	0.000998	0.00112	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—HRAS—bile duct cancer	0.000997	0.00112	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—GNAS—bile duct cancer	0.000992	0.00111	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—SMAD4—bile duct cancer	0.000982	0.0011	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TGFBR2—bile duct cancer	0.000981	0.0011	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—SMAD4—bile duct cancer	0.000974	0.00109	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—GNAS—bile duct cancer	0.000962	0.00108	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—IL6—bile duct cancer	0.000954	0.00107	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	0.000947	0.00106	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—GNAS—bile duct cancer	0.000947	0.00106	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—SMAD4—bile duct cancer	0.000944	0.00106	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TGFBR2—bile duct cancer	0.000934	0.00105	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—KRAS—bile duct cancer	0.00093	0.00104	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—SMAD4—bile duct cancer	0.000929	0.00104	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—HRAS—bile duct cancer	0.000927	0.00104	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TGFBR2—bile duct cancer	0.000909	0.00102	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—TP53—bile duct cancer	0.000907	0.00102	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—GNAS—bile duct cancer	0.000901	0.00101	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—IL6—bile duct cancer	0.000887	0.000995	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—SMAD4—bile duct cancer	0.000884	0.000992	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—GNAS—bile duct cancer	0.000876	0.000983	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TGFBR2—bile duct cancer	0.000875	0.000981	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—HRAS—bile duct cancer	0.000868	0.000973	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TGFBR2—bile duct cancer	0.000864	0.000969	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—NRAS—bile duct cancer	0.000864	0.000969	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—SMAD4—bile duct cancer	0.00086	0.000965	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—GNAS—bile duct cancer	0.000844	0.000946	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—GNAS—bile duct cancer	0.000834	0.000935	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—SMAD4—bile duct cancer	0.000828	0.000929	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—TP53—bile duct cancer	0.000826	0.000927	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—SMAD4—bile duct cancer	0.000818	0.000918	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—TGFB1—bile duct cancer	0.000802	0.0009	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—HRAS—bile duct cancer	0.00079	0.000886	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—NRAS—bile duct cancer	0.000769	0.000863	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—KRAS—bile duct cancer	0.000743	0.000834	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—NOS2—bile duct cancer	0.000731	0.00082	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TGFBR2—bile duct cancer	0.000726	0.000815	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—NRAS—bile duct cancer	0.000702	0.000787	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—EGFR—bile duct cancer	0.000701	0.000786	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—GNAS—bile duct cancer	0.000701	0.000786	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—SMAD4—bile duct cancer	0.000688	0.000771	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—NRAS—bile duct cancer	0.000681	0.000763	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TGFBR2—bile duct cancer	0.000675	0.000757	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—NRAS—bile duct cancer	0.00067	0.000751	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—KRAS—bile duct cancer	0.000662	0.000742	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—TP53—bile duct cancer	0.000661	0.000741	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—GNAS—bile duct cancer	0.000651	0.000731	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—EGFR—bile duct cancer	0.000639	0.000717	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—SMAD4—bile duct cancer	0.000639	0.000717	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—NRAS—bile duct cancer	0.000637	0.000715	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—HRAS—bile duct cancer	0.000632	0.000709	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—EGFR—bile duct cancer	0.00062	0.000696	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—NRAS—bile duct cancer	0.00062	0.000695	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—EGFR—bile duct cancer	0.00061	0.000684	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—KRAS—bile duct cancer	0.000604	0.000678	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—ERBB2—bile duct cancer	0.000597	0.00067	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—NRAS—bile duct cancer	0.000597	0.000669	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—NRAS—bile duct cancer	0.00059	0.000661	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—KRAS—bile duct cancer	0.000586	0.000657	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—EGFR—bile duct cancer	0.000581	0.000651	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—KRAS—bile duct cancer	0.000576	0.000646	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—EGFR—bile duct cancer	0.000565	0.000634	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—HRAS—bile duct cancer	0.000563	0.000631	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—ERBB2—bile duct cancer	0.00055	0.000616	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—KRAS—bile duct cancer	0.000548	0.000615	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—ERBB2—bile duct cancer	0.000545	0.000611	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—EGFR—bile duct cancer	0.000544	0.00061	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—IL6—bile duct cancer	0.000539	0.000604	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—PTGS2—bile duct cancer	0.000537	0.000603	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—EGFR—bile duct cancer	0.000537	0.000603	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—KRAS—bile duct cancer	0.000534	0.000598	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—ERBB2—bile duct cancer	0.000529	0.000593	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—ERBB2—bile duct cancer	0.00052	0.000583	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—KRAS—bile duct cancer	0.000514	0.000576	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—HRAS—bile duct cancer	0.000513	0.000576	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—MMP9—bile duct cancer	0.000512	0.000575	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—KRAS—bile duct cancer	0.000508	0.000569	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—HRAS—bile duct cancer	0.000498	0.000559	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—ERBB2—bile duct cancer	0.000495	0.000555	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—IL6—bile duct cancer	0.000491	0.000551	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—IDH2—bile duct cancer	0.00049	0.00055	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—HRAS—bile duct cancer	0.00049	0.000549	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—ERBB2—bile duct cancer	0.000481	0.00054	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—IL6—bile duct cancer	0.000477	0.000535	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—IL6—bile duct cancer	0.000469	0.000526	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—MMP9—bile duct cancer	0.000467	0.000524	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—HRAS—bile duct cancer	0.000466	0.000523	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—ERBB2—bile duct cancer	0.000463	0.00052	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—NRAS—bile duct cancer	0.000461	0.000517	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—ERBB2—bile duct cancer	0.000458	0.000514	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—NRAS—bile duct cancer	0.000454	0.00051	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—HRAS—bile duct cancer	0.000454	0.000509	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—MMP9—bile duct cancer	0.000453	0.000508	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—IL6—bile duct cancer	0.000446	0.000501	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—MMP9—bile duct cancer	0.000446	0.0005	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—HRAS—bile duct cancer	0.000437	0.00049	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—IL6—bile duct cancer	0.000434	0.000487	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—HRAS—bile duct cancer	0.000431	0.000484	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—MMP9—bile duct cancer	0.000424	0.000476	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TGFB1—bile duct cancer	0.000422	0.000474	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—IDH1—bile duct cancer	0.000422	0.000473	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—EGFR—bile duct cancer	0.00042	0.000471	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—NRAS—bile duct cancer	0.000418	0.000469	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—IL6—bile duct cancer	0.000418	0.000469	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—NRAS—bile duct cancer	0.000415	0.000465	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—EGFR—bile duct cancer	0.000414	0.000464	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—MMP9—bile duct cancer	0.000413	0.000463	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—IL6—bile duct cancer	0.000413	0.000463	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—NRAS—bile duct cancer	0.000402	0.000451	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—MMP9—bile duct cancer	0.000397	0.000446	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—KRAS—bile duct cancer	0.000397	0.000445	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—NRAS—bile duct cancer	0.000396	0.000444	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—MMP9—bile duct cancer	0.000393	0.000441	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—KRAS—bile duct cancer	0.000391	0.000439	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—TGFB1—bile duct cancer	0.000388	0.000436	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TGFB1—bile duct cancer	0.000385	0.000432	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—ERBB2—bile duct cancer	0.000385	0.000432	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—EGFR—bile duct cancer	0.000381	0.000427	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—EGFR—bile duct cancer	0.000378	0.000424	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—NRAS—bile duct cancer	0.000376	0.000422	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TGFB1—bile duct cancer	0.000374	0.000419	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TGFB1—bile duct cancer	0.000368	0.000412	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—EGFR—bile duct cancer	0.000366	0.000411	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—NRAS—bile duct cancer	0.000366	0.000411	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—EGFR—bile duct cancer	0.00036	0.000404	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—KRAS—bile duct cancer	0.00036	0.000404	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—ERBB2—bile duct cancer	0.000358	0.000401	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—KRAS—bile duct cancer	0.000357	0.0004	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—NRAS—bile duct cancer	0.000353	0.000395	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TGFB1—bile duct cancer	0.00035	0.000392	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—NRAS—bile duct cancer	0.000348	0.000391	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TP53—bile duct cancer	0.000348	0.00039	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—KRAS—bile duct cancer	0.000346	0.000388	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—EGFR—bile duct cancer	0.000343	0.000385	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—KRAS—bile duct cancer	0.00034	0.000382	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TGFB1—bile duct cancer	0.00034	0.000382	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—HRAS—bile duct cancer	0.000337	0.000378	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—EGFR—bile duct cancer	0.000334	0.000374	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—HRAS—bile duct cancer	0.000332	0.000373	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MMP9—bile duct cancer	0.00033	0.00037	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TGFB1—bile duct cancer	0.000328	0.000367	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—KRAS—bile duct cancer	0.000324	0.000363	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TGFB1—bile duct cancer	0.000324	0.000363	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—IL6—bile duct cancer	0.000323	0.000362	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—EGFR—bile duct cancer	0.000321	0.00036	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—IL6—bile duct cancer	0.000318	0.000357	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—EGFR—bile duct cancer	0.000317	0.000356	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TP53—bile duct cancer	0.000317	0.000356	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—KRAS—bile duct cancer	0.000315	0.000354	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TP53—bile duct cancer	0.000308	0.000345	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MMP9—bile duct cancer	0.000307	0.000344	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—HRAS—bile duct cancer	0.000306	0.000343	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—KRAS—bile duct cancer	0.000303	0.00034	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—HRAS—bile duct cancer	0.000303	0.00034	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TP53—bile duct cancer	0.000303	0.000339	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—KRAS—bile duct cancer	0.0003	0.000336	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—HRAS—bile duct cancer	0.000294	0.00033	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—NRAS—bile duct cancer	0.000293	0.000328	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—IL6—bile duct cancer	0.000293	0.000328	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—IL6—bile duct cancer	0.00029	0.000326	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—HRAS—bile duct cancer	0.000289	0.000325	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TP53—bile duct cancer	0.000288	0.000323	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—IL6—bile duct cancer	0.000282	0.000316	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TP53—bile duct cancer	0.00028	0.000314	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—SLC5A5—bile duct cancer	0.000278	0.000312	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—IL6—bile duct cancer	0.000277	0.000311	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—HRAS—bile duct cancer	0.000275	0.000309	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NRAS—bile duct cancer	0.000272	0.000305	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TGFB1—bile duct cancer	0.000272	0.000305	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TP53—bile duct cancer	0.00027	0.000302	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—HRAS—bile duct cancer	0.000268	0.000301	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—EGFR—bile duct cancer	0.000267	0.000299	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TP53—bile duct cancer	0.000266	0.000299	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—IL6—bile duct cancer	0.000264	0.000296	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000261	0.000292	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—HRAS—bile duct cancer	0.000258	0.000289	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—IL6—bile duct cancer	0.000256	0.000288	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—HRAS—bile duct cancer	0.000255	0.000286	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TGFB1—bile duct cancer	0.000253	0.000284	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—KRAS—bile duct cancer	0.000252	0.000283	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—EGFR—bile duct cancer	0.000248	0.000278	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—IL6—bile duct cancer	0.000247	0.000277	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—IL6—bile duct cancer	0.000244	0.000274	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—KRAS—bile duct cancer	0.000234	0.000263	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TP53—bile duct cancer	0.000224	0.000251	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GNAS—bile duct cancer	0.000216	0.000243	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—HRAS—bile duct cancer	0.000214	0.00024	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TP53—bile duct cancer	0.000208	0.000234	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IL6—bile duct cancer	0.000205	0.00023	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—HRAS—bile duct cancer	0.000199	0.000223	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IL6—bile duct cancer	0.000191	0.000214	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PTGS2—bile duct cancer	0.000116	0.00013	CbGpPWpGaD
